Skip to content

Healthy Growth Strategy 2022–2025

Raisio’s main goal during the strategy period is to grow based on the new capabilities, increased capacity and new product categories.

Raisio’s Healthy Growth Strategy is based on three focus areas

Benecol® and plant stanol ester solutions

Raisio continues to invest in growing the international Benecol® brand. Plant stanol ester in Benecol® products has been shown to lower cholesterol and the health claim has been approved by the EU commission. Furthermore, Raisio invests also in a research program to study other potential health beneficial properties of plant stanol ester.

Benecol® and plant stanol ester solutions are key contributors to Raisio’s profitability. Our goal is to increase the net sales from these products by an average of 3 per cent annually (CAGR) in 2020–2025.

Value added oats and ingredients

Raisio continues to expand internationally in the B2B as well as the consumer market based on the company’s strong expertise in oats. Our goal is to grow the net sales from these products faster than the market, i.e., by an average of 12 per cent annually (CAGR) in 2020–2025.

Plant-based products

Consumer choices are increasingly directed towards healthy and sustainably produced, plant-based food. Raisio wants to strengthen its position in this promising and fast-growing market in Finland as well as internationally. Our goal is to increase the net sales from these products by an average of 38 per cent annually (CAGR) in 2021–2025.

 

Raisio's growth drivers 2022-2025

Trends supporting
Raisio’s strategy

Today, health is perceived in an increasingly holistic way, and the significance of mental wellbeing is growing. At the same time, plant-based diets are becoming more popular and expanding to new product categories. Appreciation for sustainable food production is on the rise as well. These trends support Raisio’s Healthy Growth strategy well.

Raisio’s Financial Targets ​2022−2025*

Growth

The compound annual growth rate (CAGR) of the combined net sales from the three focus areas is 7% during the strategy period, and the CAGR for the entire Raisio Group is 5%.

Profitability

Raisio targets a comparable EBIT of over 10 per cent of the Group’s net sales in 2025. The commissioning and commercialisation stage of the new production facility and growth investments in Verso Food, acquired in spring 2021, put pressure on Raisio’s profitability during the first years of the strategy period.

*The targets have been defined for Raisio’s current company structure on June 10th 2021 and do not include potential business acquisitions.​

Search